Dr. Sallie Permar is a physician scientist whose work focuses on the prevention and treatment of neonatal viral infections and the immunology of the maternal-fetal interface. 

She has a PhD in Microbiology/Immunology from Johns Hopkins Bloomberg School of Public Health in Baltimore, an M.D. from Harvard Medical School, and completed her clinical training in pediatric infectious diseases at Children’s Hospital in Boston. 

In addition to caring for patients with congenital infections, she leads a research laboratory investigating immune protection against vertical transmission of neonatal viral pathogens, including HIV-1, cytomegalovirus, and Zika. She has made important contributions to the development of vaccines for prevention of vertical HIV, CMV, and Zika transmission utilizing novel nonhuman primate models, and is leading clinical pediatric HIV vaccine trials. Dr. Permar has received several prestigious early-stage investigator awards, including the Presidential Early Career Award in Science and Engineering (PECASE), the Society for Pediatrics Research (SPR) Young Investigator Award, and induction into the American Society of Clinical Investigation.